BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23300362)

  • 1. Population-based home care services in breast cancer: utilization and costs.
    Mittmann N; Isogai PK; Saskin R; Liu N; Porter JM; Cheung MC; Leighl NB; Hoch JS; Trudeau ME; Evans WK; Dainty KN; Earle CC
    Curr Oncol; 2012 Dec; 19(6):e383-91. PubMed ID: 23300362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and costs of home care for patients with colorectal cancer: a population-based study.
    Mittmann N; Liu N; Porter J; Seung SJ; ; Isogai PK; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau M; Evans WK; Dainty KN; Earle CC
    CMAJ Open; 2014 Jan; 2(1):E11-7. PubMed ID: 25077120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health system costs for stage-specific breast cancer: a population-based approach.
    Mittmann N; Porter JM; Rangrej J; Seung SJ; Liu N; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau M; Evans WK; Dainty KN; DeAngelis C; Earle CC
    Curr Oncol; 2014 Dec; 21(6):281-93. PubMed ID: 25489255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.
    Wilkinson AN; Seely JM; Rushton M; Williams P; Cordeiro E; Allard-Coutu A; Look Hong NJ; Moideen N; Robinson J; Renaud J; Mainprize JG; Yaffe MJ
    Curr Oncol; 2023 Aug; 30(9):7860-7873. PubMed ID: 37754486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-of-life home care utilization and costs in patients with advanced colorectal cancer.
    Mittmann N; Liu N; Porter JM; Isogai PK; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau ME; Evans WK; Dainty KN; Earle CC
    J Community Support Oncol; 2014 Mar; 12(3):92-8. PubMed ID: 24971414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach.
    Khan SA; Hernandez-Villafuerte K; Hernandez D; Schlander M
    Front Public Health; 2022; 10():946544. PubMed ID: 36684975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey.
    Zhao Y; Luo H; Zhang X; Bianba T; Li L; Wang Q; Guo L; Wang D; Ze Y; Zheng S
    BMC Cancer; 2019 Apr; 19(1):380. PubMed ID: 31023263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 9. Healthcare costs associated with breast cancer in Germany: a claims data analysis.
    Kreis K; Plöthner M; Schmidt T; Seufert R; Schreeb K; Jahndel V; Maas S; Kuhlmann A; Zeidler J; Schramm A
    Eur J Health Econ; 2020 Apr; 21(3):451-464. PubMed ID: 31897812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.
    Hurry M; Hassan S; Seung SJ; Walton RN; Elnoursi A; McGee JD
    J Health Econ Outcomes Res; 2021; 8(2):114-121. PubMed ID: 34993257
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal Remote Monitoring of Women With Gestational Hypertensive Diseases: Cost Analysis.
    Lanssens D; Vandenberk T; Smeets CJ; De Cannière H; Vonck S; Claessens J; Heyrman Y; Vandijck D; Storms V; Thijs IM; Grieten L; Gyselaers W
    J Med Internet Res; 2018 Mar; 20(3):e102. PubMed ID: 29581094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
    Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
    Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents.
    Kelly EM; James PD; Murthy S; Antonova L; Wong F; Shaw-Stiffel T; Chalifoux M; Salim M; Tanuseputro P
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2339-2346.e1. PubMed ID: 30743007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
    Héquet D; Huchon C; Soilly AL; Asselain B; Berseneff H; Trichot C; Combes A; Alves K; Nguyen T; Rouzier R; Baffert S
    PLoS One; 2019; 14(7):e0210917. PubMed ID: 31291250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review.
    Palacios A; Rojas-Roque C; González L; Bardach A; Ciapponi A; Peckaitis C; Pichon-Riviere A; Augustovski F
    Pharmacoeconomics; 2021 May; 39(5):485-502. PubMed ID: 33782865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
    Sloan FA; Yashkin AP; Akushevich I; Inman BA
    Urol Oncol; 2020 Feb; 38(2):39.e11-39.e19. PubMed ID: 31761612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
    Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
    Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Childhood Cancer Care Costs in Two Canadian Provinces.
    McBride ML; de Oliveira C; Duncan R; Bremner KE; Liu N; Greenberg ML; Nathan PC; Rogers PC; Peacock SJ; Krahn MD
    Healthc Policy; 2020 Feb; 15(3):76-88. PubMed ID: 32176612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.